ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 312 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $42,000 | -6.7% | 1,201 | +22.4% | 0.00% | – |
Q1 2022 | $45,000 | -25.0% | 981 | +7.9% | 0.00% | – |
Q4 2021 | $60,000 | +9.1% | 909 | +4.0% | 0.00% | – |
Q3 2021 | $55,000 | -21.4% | 874 | +3.6% | 0.00% | -100.0% |
Q2 2021 | $70,000 | -76.8% | 844 | -81.5% | 0.00% | -66.7% |
Q1 2021 | $302,000 | -6.2% | 4,557 | +8.5% | 0.00% | -25.0% |
Q4 2020 | $322,000 | +94.0% | 4,200 | +13.5% | 0.00% | +33.3% |
Q3 2020 | $166,000 | +7.1% | 3,700 | +5.7% | 0.00% | 0.0% |
Q2 2020 | $155,000 | +66.7% | 3,500 | 0.0% | 0.00% | +50.0% |
Q1 2020 | $93,000 | – | 3,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |